CDK2 and non-small cell lung carcinoma: Our previous report demonstrated that pemetrexed-induced apoptosis was closely associated with S-phase accumulation, as well as sustained Cdk2/cyclin A-associated kinase activation in human non-small cell lung cancer A549 cells [21].